These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Bactericidal activity of ceftriaxone, amikacin and their combination].
    Author: Juvin ME, Drugeon HB, Bigot E, Caillon J.
    Journal: Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):554-8. PubMed ID: 3534741.
    Abstract:
    Third-generation cephalosporins such as ceftriaxone are often used alone; however, with Enterobacter (ENT), Citrobacter (CIT), Serratia (SER) and Morganella (MOR), a combination of two drugs is advisable. Aminoglycoside-beta-lactam combinations are often synergistic. However, results are not consistent with the new cephalosporins. We determined the killing kinetics of ceftriaxone (C) alone, amikacin (A) alone and both drugs in combination (AC). The antibiotics were tested in the following concentrations: 0.25, 1, 4 and 16 X MIC for C, 0.5, 2 and 8 X MIC for A, and, for AC, 0.5-0.25 X MIC (1), 0.5-1 X MIC (2) and 2-0.25 X MIC (3). Surviving bacteria were enumerated at 0 h, 1 h, 3 h, 5 h and 24 hours. Amikacin showed a strong, dose-dependent bactericidal activity. Maximal activity of ceftriaxone was observed at 1 or 4 X MIC. Time of contact had a significant influence, indicating a time-dependent activity. In 5 hours, the killing effect of the AC combination rarely exceeded that of each antibiotic alone. Higher killing rates were observed with AC and; the killing effect of AC (3) was similar to amikacin's maximal killing effect. In 24 hours, the AC (3) combination was clearly synergistic with inhibition of late regrowths.
    [Abstract] [Full Text] [Related] [New Search]